Scientists have developed a simple test that can identify 18 early-stage cancers that experts say could represent a medical “gamechanger.”
Cancer accounts for one in every six deaths worldwide, but early detection can significantly improve outcomes.
Existing screening tests have drawbacks, including invasiveness, cost and low levels of accuracy for early stage disease.
Photo: EPA-EFE
Now US researchers have designed a test that analyses proteins in the blood and can pick up 18 early stage cancers, representing all main organs in the human body.
Specific blood proteins could already be used for early detection and monitoring, but until now tests have lacked sensitivity — accuracy of picking up those with cancer — and specificity — accuracy of excluding those without cancer, the researchers said.
The team, from the US biotech firm Novelna, said their test outperformed others relying on tumor DNA in the blood, and had “a sensitivity much greater” than the Galleri test being trialed on the NHS in the UK.
Photo: AFP
By looking at proteins in blood plasma, the experts were able to differentiate cancer samples from normal ones, and even distinguish between different types of cancers “with high accuracy,” they said. The research also found evidence that cancer protein signals were likely to be sex-specific.
Writing in the journal BMJ Oncology, the team said: “This finding is the foundation for a multi-cancer screening test for the early detection of 18 solid tumors that cover all major human organs of origin for such cancers at the earliest stage of their development with high accuracy.”
They added: “This could re-shape screening guidelines, making this plasma test a standard part of routine check-ups.”
Photo: AP
“These findings pave the way for a cost-effective, highly accurate, multi-cancer screening test that can be implemented on a population-wide scale.”
Blood plasma samples were collected from 440 people diagnosed with 18 different types of cancer, and from 44 healthy blood donors.
The team then identified proteins which showed early stage cancers and where they originated in the body “with high accuracy.”
The team wrote: “At stage I (the earliest cancer stage) and at the specificity of 99 percent, our panels were able to identify 93 percent of cancers among males and 84 percent of cancers among females.
“Our sex-specific localization panels consisted of 150 proteins and were able to identify the tissue of origin of most cancers in more than 80 percent of cases.”
Analysis of the plasma protein also showed almost all of them were present at very low levels. This shows the importance of low-level proteins to pick up pre-cancerous and early stage disease before a tumor has had time to cause substantial damage, the team said.
But the team said their relatively small sample size meant further studies were needed in bigger groups of people.
Mangesh Thorat, of the Centre for Cancer Prevention at the Wolfson Institute of Preventive Medicine, who was not involved with the study, said there remained questions about the test and more studies were needed.
“However, the interesting aspects of this assay are a much higher sensitivity for stage I cancers than other similar assays in development and gender-specific performance differences which are biologically and clinically relevant,” he said.
“If the assay performance in future, well-designed sequential studies is anywhere close to what this preliminary study suggests, then it could really be a gamechanger.”
Prof Paul Pharoah, a cancer epidemiology expert at Cedars-Sinai Medical Center, who was also not involved in the study, welcomed the findings but urged caution.
“Simple blood tests that can detect many different cancers in the early stages (test is sensitive) and do not generate false positives (test is specific) are a holy grail for early detection,” he said.
“This paper reports on the initial results of the development of one such test. While the results show some promise, it is far too soon to be confident that this test will turn out to be useful for early cancer detection.”
Paul Thomas Anderson’s “One Battle After Another” was crowned best picture at the 98th Academy Awards, handing Hollywood’s top honor to a comic, multi-generational American saga of political resistance. The ceremony Sunday, which also saw Michael B. Jordan win best actor and “Sinners” cinematographer Autumn Durald Arkapaw make Oscar history as the first female director of photography to win the award, was a long-in-coming coronation for Anderson, a San Fernando Valley native who made his first short at age 18 and has been one of America’s most lionized filmmakers for decades. Before Sunday, Anderson had never won an Oscar. But “One Battle
In Kaohsiung’s Indigenous People’s Park (原住民主題公園), the dance group Push Hands is training. All its members are from Taiwan’s indigenous community, but their vibe is closer to that of a modern, urban hip-hop posse. MIXING CULTURES “The name Push Hands comes from the idea of pushing away tradition to expand our culture,” says Ljakuon (洪濬嚴), the 44-year-old founder and main teacher of the dance group. This is what makes Push Hands unique: while retaining their Aboriginal roots, and even reconnecting with them, they are adamant about doing something modern. Ljakuon started the group 20 years ago, initially with the sole intention of doing hip-hop dancing.
You would never believe Yancheng District (鹽埕) used to be a salt field. Today, it is a bustling, artsy, Kowloon-ish “old town” of Kaohsiung — full of neon lights, small shops, scooters and street food. Two hundred years ago, before Japanese occupiers developed a shipping powerhouse around it, Yancheng was a flat triangle where seawater was captured and dried to collect salt. This is what local art galleries are revealing during the first edition of the Yancheng Arts Festival. Shen Yu-rung (沈裕融), the main curator, says: “We chose the connection with salt as a theme. The ocean is still very near, just a
A key feature of Taiwan’s environmental impact assessments (EIA) is that they seldom stop projects, especially once the project has passed its second stage EIA review (the original Suhua Highway proposal, killed after passing the second stage review, seems to be the lone exception). Mingjian Township (名間鄉) in Nantou County has been the site of rising public anger over the proposed construction of a waste incinerator in an important agricultural area. The township is a key producer of tea (over 40 percent of the island’s production), ginger and turmeric. The incinerator project is currently in its second stage EIA. The incinerator
RSS